Rabdosia rubescens Inhibits CYP7A1 Expression and Induces Autophagy to Reduce Alcohol‐Induced Liver Damage in Mice

Investigating the antialcoholic liver injury properties of Rabdosia rubescens and its effect on the expression of CYP7A1 and levels of autophagy.

• Publication year

  2025

• Venue

  Canadian Journal of Gastroenterology and Hepatology

• Publication date

  2025-01-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1155/cjgh/9507266PMID 41079251PMCID 12512039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanisms of alcohol-associated liver disease-ferroptosis and autophagy crosstalk

  2025cited by this paper
• Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review

  2024cited by this paper
• Establishment and application of murine models of alcoholic liver disease: A narrative review.

  2024cited by this paper
• Rabdosia rubescens (Hemsl.) H. Hara: A Potent Anti-Tumor Herbal Remedy - Botany, Phytochemistry, and Clinical Breakthroughs.

  2024influential reference
• Ferulic Acid Alleviates Lipid and Bile Acid Metabolism Disorders by Targeting FASN and CYP7A1 in Iron Overload-Treated Mice

  2024cited by this paper
• Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

  2024cited by this paper
• Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner

  2023cited by this paper
• Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis

  2023cited by this paper
• Global burden of Liver Disease: 2023 Update.

  2023cited by this paper
• Isodon rubescens (Hemls.) Hara.: A Comprehensive Review on Traditional Uses, Phytochemistry, and Pharmacological Activities

  2022cited by this paper
• Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

  2022cited by this paper
• Epidemiology and Disease Burden of Alcohol Associated Liver Disease.

  2022cited by this paper
• SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR

  2022cited by this paper
• New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

  2022cited by this paper
• Advancements in the Alcohol-Associated Liver Disease Model

  2022cited by this paper
• Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease

  2022cited by this paper
• Autophagy in liver diseases: A review.

  2021cited by this paper
• SREBP-1c and lipogenesis in the liver: an update1.

  2021cited by this paper
• Oridonin Alters Hepatic Urea Cycle via Gut Microbiota and Protects against Acetaminophen-Induced Liver Injury

  2021cited by this paper
• Role and mechanisms of autophagy in alcohol-induced liver injury.

  2019cited by this paper
• Role of autophagy in alcohol and drug-induced liver injury.

  2019cited by this paper
• Alcohol, liver disease and the gut microbiota

  2019cited by this paper
• Alcoholic Hepatitis: A Review.

  2019cited by this paper
• Alcoholic liver disease

  2018cited by this paper
• Alcoholic liver disease

  2018cited by this paper
• Bile Acid Metabolism in Liver Pathobiology.

  2018cited by this paper
• Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma

  2018cited by this paper
• Pathology of Alcoholic Liver Disease

  2014cited by this paper
• Intrahepatic cholestasis in common chronic liver diseases

  2013cited by this paper
• Mouse model of chronic and binge ethanol feeding (the NIAAA model)

  2013cited by this paper
• Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.

  2013cited by this paper
• Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

  2012cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model.

  2006cited by this paper
• Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)*

  2002cited by this paper
• A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

  2000cited by this paper
• [Pathology of alcoholic liver disease].

  2000cited by this paper
• The Journal of

  1998cited by this paper

• No citing papers are available for this paper.